Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Infection|April 11, 2022
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjectsVivian Glück, Leonid Tydykov, Anna-Lena Mader, et al.
Vaccines|February 26, 2022
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected ParticipantsDavid Peterhoff, Sebastian Einhauser, Stephanie Beileke, et al.
NPJ Vaccines|December 15, 2025
Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbitsFrederik Radvan, Alexandra Hauser, Li-Yun Lin, et al.
Perfusion|February 22, 2021
ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factorsEsther Dreier, Maximilian Valentin Malfertheiner, Thomas Dienemann, et al.
Clinical Immunology (Orlando, Fla.)|April 26, 2025
Hyper-reactivity of CD8<sup>+</sup> T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVIDKerstin Renner, Franz Stauffenberg, Moritz Paulus, et al.
Vaccines|August 6, 2021
Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody ResponsesAlexandra Hauser, George Carnell, Kathrin Held, et al.
Frontiers in Immunology|January 11, 2020
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune ResponsesBeatriz Perdiguero, Carmen Elena Gómez, Juan García-Arriaza, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2021
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entryJulián Valero, Laia Civit, Daniel M Dupont, et al.
Iscience|March 21, 2022
Omicron's binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individualsAnna-Lena Mader, Leonid Tydykov, Vivian Glück, et al.
Plos One|December 22, 2020
Manufacturing of convalescent plasma of COVID-19 patients: Aspects of qualityViola Hähnel, David Peterhoff, Veronika Bäuerlein, et al.
Pageof 6